Search

everythinglearnresearchcommunity

for

Search:↓

Four specific genes are linked to keloid formation and could be potential treatment targets.

Baricitinib improved hair loss and arthritis in a lupus patient.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Human head hair proteins can be typed into eight distinct patterns, useful for genetic and forensic investigations.

Alopecia areata patients have higher oxidative stress and lower antioxidant levels.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Autoimmunity can cause both alopecia areata and idiopathic primary hypophysitis.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

The document concludes that secondary syphilis cases are increasing and often misdiagnosed, pityriasis rubra pilaris can be distinguished from psoriasis by skin cell features, and different skin layers produce specific components during skin repair.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Lower MC2R expression may contribute to alopecia areata.

Key proteins and potential drugs for treating alopecia areata were identified.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

The skin of both rat strains showed similar lectin binding patterns.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

The research found a way to identify and study skin cells with stem cell traits, revealing they behave differently in culture and questioning current stemness assessment methods.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Combining genetic and physical trait analysis improves diagnosis accuracy for monogenic diabetes.

Alopecia can be a symptom of Neonatal Lupus.

SII is a useful and affordable tool to assess and monitor alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.